Skin Care :: SCULPTRA for facial fat loss – lipoatrophy
The U.S. Food and Drug Administration (FDA) advisory committee recently approved SCULPTRA (injectable poly-L-lactic acid) for use in correcting shape and contour deficiencies resulting from facial fat loss (lipoatrophy) in people with human immunodeficiency virus (HIV).